JERSEY, Channel Islands, Feb. 01, 2016 -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ending December 31, 2015 will be released before the market opens on Monday, February 8th, 2016.
Quotient will host a conference call on Monday, February 8th at 8:30 a.m. Eastern Time to discuss its third quarter fiscal 2016 financial results. Participants may access the call by dialing 1-877-407-9039 in the U.S. or 1-201-689-8470 outside the U.S. The conference call will be webcast live on the Company's website at www.quotientbd.com.
A replay of this conference call will be available through February 15 by dialing 1-877-870-5176 in the U.S. or 1-858-384-5517 outside the U.S. The replay access code is 13629523.
About Quotient Limited
Quotient is a commercial-stage diagnostics company committed to reducing healthcare costs and improving patient care through the provision of innovative tests within established markets. With an initial focus on blood grouping and serological disease screening, Quotient is developing its proprietary MosaiQTM technology platform to offer a breadth of tests that is unmatched by existing commercially available transfusion diagnostic instrument platforms. The company’s operations are based in Edinburgh, Scotland; Eysins, Switzerland and Newtown, Pennsylvania.
CONTACT: Stephen Unger, Chief Financial Officer – [email protected]; (212) 228-7572


Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 



